← Back to patent-cliff list
CAS 4235-43-2
methyl 5-chloro-4-acetamido-2-ethoxybenzoate
Codes: Mosapride Citrate-004
Application context (from source-drug indications)
GastritisMosapride CitrateEnteral feeding intoleranceMosapride CitrateIrritable bowel syndromeMosapride CitrateDyspepsiaMosapride CitrateConstipationMosapride Citrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Mosapride Citrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Methyl 4-(acetylamino)-2-hydroxybenzoate→1-Iodoethane→methyl 4-acetamido-2-ethoxybenzoate→methyl 5-chloro-4-acetamido-2-ethoxybenzoate→4-Amino-5-chloro-2-ethoxybenzoic acid→[4-(4-Fluorobenzyl)-2-morpholinyl]methylamine→Mosapride Citrate-007
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.